DC
RIGL icon

Deere & Company’s Rigel Pharmaceuticals RIGL Stock Holding History

Deere & Company’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-15,798
Closed -$507K – 1024
2015
Q2 		$507K Buy
+15,798
New +$603K 0.03% 642

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Deere & Company's RIGL Position: Q3 2015 in Review

Deere & Company sold out of Rigel Pharmaceuticals (RIGL) in Q3 2015, closing a stake of 15,798 shares — an estimated $507K sold.

Deere & Company first reported a position in RIGL in Q2 2015 and held it in 1 quarter. The position peaked at $507K in Q2 2015. 122 funds tracked by Wall St. Rank hold RIGL as of Q3 2015.

  • Deere & Company reported no remaining Rigel Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Deere & Company sold 15,798 Rigel Pharmaceuticals shares in Q3 2015, an estimated $507K.
  • Deere & Company first reported a position in Rigel Pharmaceuticals in Q2 2015 and held it in 1 quarter.
  • Deere & Company's Rigel Pharmaceuticals position peaked at $507K in Q2 2015.
  • 122 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2015.

Based on Deere & Company's 13F filing for Q3 2015, filed 12 Nov 2015.